Prospective Study for the Prognostic and Predictive Role of Circulating Tumor Cells in Patients With Oropharyngeal Squamous Cell Carcinoma: CTCO (Circulating Tumor Cells in the Oropharynx)

RecruitingOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

June 23, 2021

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
Circulating Tumor CellOropharyngeal Cancer
Interventions
BIOLOGICAL

CTC detection

"The collection and analysis of CTCs will be carried out in the following 6 steps: A blood sample will be taken: a maximum volume of 30 ml on 3 x 10 ml BD Vacutainer® EDTA tubes is required for the study.~CTCs will be enumerated and characterized by immunofluorescence after immunostaining with the following antibodies: anticytokeratin, anti-CD44, anti-N-cadherin and anti-PD-L1.~• - Secondary criterion(s) : Different tumor and clinical parameters will be analysed to find a correlation with CTC detection Gene expression profiles will be analyzed using the RNAseq single-cell at different times: before treatment, at interim times, and in case of relapse in order to establish correlations between patients at high risk of relapse and their molecular profiles"

Trial Locations (1)

69004

RECRUITING

Service ORL Chirurgie Cervico-faciale (Pr Philippe CERUSE), Lyon

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER